These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28691689)

  • 1. A case of a focal oedematous reaction induced by rituximab overlying lupus erythematosus tumidus.
    Bohelay G; Rousset L; Levy A; Arana R; Laroche L; Caux F
    Eur J Dermatol; 2017 Oct; 27(5):542-543. PubMed ID: 28691689
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-beta injection site reaction: review of the histology and report of a lupus-like pattern.
    Conroy M; Sewell L; Miller OF; Ferringer T
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S48-9. PubMed ID: 18625386
    [No Abstract]   [Full Text] [Related]  

  • 3. Pustuloderma during cutaneous lupus treatment with thalidomide.
    Rúa-Figueroa I; Erausquin C; Naranjo A; Carretero-Hernández G; Rodriguez-Lozano C; De la Rosa P
    Lupus; 1999; 8(3):248-9. PubMed ID: 10342720
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
    Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
    Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yellow skin discoloration induced by quinacrine in a patient with cutaneous lupus erythematosus.
    Vidal D; Altés J; Smandia JA
    Actas Dermosifiliogr; 2013 Jan; 104(1):89-90. PubMed ID: 22831783
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of severe subacute cutaneous lupus erythematosus with rituximab in an adolescent.
    Dodds M; Hobday P; Schultz B; Maguiness S
    Pediatr Dermatol; 2018 May; 35(3):e189-e190. PubMed ID: 29570834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Chen W; Song X; Zhou Y
    J Dtsch Dermatol Ges; 2024 Jul; 22(7):1003-1005. PubMed ID: 38664067
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab-induced urticarial dermatitis during the treatment of membranous nephropathy.
    Radhakrishnan RC; Basu G; George RE; Parmar H; Tamilarasi V
    Saudi J Kidney Dis Transpl; 2017; 28(3):657-660. PubMed ID: 28540910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of incapacitating acute cutaneous lupus erythematosus in a patient with systemic lupus erythematosus by B cell-depletive therapy.
    Kok MR; Vos K; Bos JD; Tak PP
    J Clin Rheumatol; 2010 Oct; 16(7):345. PubMed ID: 20859218
    [No Abstract]   [Full Text] [Related]  

  • 11. Subacute-cutaneous lupus erythematosus induced by Simvastatin.
    Rüger RD; Simon JC; Treudler R
    J Dtsch Dermatol Ges; 2011 Jan; 9(1):54-5. PubMed ID: 21040470
    [No Abstract]   [Full Text] [Related]  

  • 12. Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab.
    Kieu V; O'Brien T; Yap LM; Baker C; Foley P; Mason G; Prince HM; McCormack C
    Australas J Dermatol; 2009 Aug; 50(3):202-6. PubMed ID: 19659984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus.
    Penha MÁ; Libório RDS; Miot HA
    An Bras Dermatol; 2018 Jun; 93(3):467-469. PubMed ID: 29924233
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful short desensitization for the eruption of hydroxychloroquine.
    Hayami T; Tanaka T; Fujimoto N
    Lupus; 2019 Jun; 28(7):918-919. PubMed ID: 31112453
    [No Abstract]   [Full Text] [Related]  

  • 15. Lupus erythematosus tumidus: an underestimated entity.
    Teixeira M; Ferreira M; Alves R; Selores M
    Lupus; 2006; 15(5):296-300. PubMed ID: 16761505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients.
    Fennira F; Chasset F; Soubrier M; Cordel N; Petit A; Francès C
    J Am Acad Dermatol; 2016 Jun; 74(6):1248-51. PubMed ID: 27185425
    [No Abstract]   [Full Text] [Related]  

  • 17. [Subacute cutaneous lupus erythematosus induced by golimumab].
    Blasco-Morente G; Notario-Ferreira I; Rueda-Villafranca B; Tercedor-Sánchez J
    Med Clin (Barc); 2015 Sep; 145(5):226-7. PubMed ID: 25547737
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic lupus erythematosus following rituximab treatment for non-Hodgkin lymphoma.
    Soura E; Avgerinou G; Papoutsaki M; Stavropoulos P; Antoniou C
    J Dtsch Dermatol Ges; 2016 Mar; 14(3):298-301. PubMed ID: 26788717
    [No Abstract]   [Full Text] [Related]  

  • 19. Lupus erythematosus tumidus: a clinical and histological study of 25 cases.
    Rodriguez-Caruncho C; Bielsa I; Fernández-Figueras MT; Roca J; Carrascosa JM; Ferrándiz C
    Lupus; 2015 Jun; 24(7):751-5. PubMed ID: 25413356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thalidomide therapy of cutaneous lupus erythematosus].
    Bohmeyer J; Achenbach A; Westenberger M; Stadler R
    Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.